Home›Companies›Biotech & Pharma›Seranova Bio

Seranova Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 5, 2024·Suggest an edit

About Seranova Bio

Seranova Bio is a private company based in South San Francisco, California, incorporated in 2020 in Delaware. It has reported $15,049,985 raised in two offerings on Form D since May 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 1, 2024Feb 5, 2024$9,999,995fully sold4$2.4MEquityRule 506(b)Form D ↗
Apr 30, 2021May 13, 2021$5,049,990fully sold2$2.5MEquityRule 506(b)Form D ↗
Total, two offerings$15,049,985

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Seranova Bio's Form D filed Feb 5, 2024.

DS
Damien Soghoian
Executive officer and director
AR
Aaron Ring
Executive officer and director
Also an associate professor, fred hutch and director at Stipple Bio.
HT
Hui Tian
Director
SO
Sabah Oney
Director
LC
Leon Chen
Director

Earlier filings also listed Jim Tananbaum (director, last listed May 2021) and Beatrice McQueen (executive officer, last listed May 2021).

Sources

  1. SECSeranova Bio, Inc. filing history